KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Change in Inventory: 2010-2024

Historic Change in Inventory for Nektar Therapeutics (NKTR) over the last 15 years, with Dec 2024 value amounting to -$1.3 million.

  • Nektar Therapeutics' Change in Inventory fell 21.85% to -$1.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$497,000, marking a year-over-year increase of 28.90%. This contributed to the annual value of -$497,000 for FY2024, which is 28.90% up from last year.
  • Latest data reveals that Nektar Therapeutics reported Change in Inventory of -$1.3 million as of Q4 2024, which was down 960.98% from -$123,000 recorded in Q3 2024.
  • Nektar Therapeutics' 5-year Change in Inventory high stood at $2.4 million for Q4 2020, and its period low was -$2.4 million during Q3 2023.
  • Over the past 3 years, Nektar Therapeutics' median Change in Inventory value was $11,000 (recorded in 2022), while the average stood at $183,750.
  • Over the last 5 years, Nektar Therapeutics' Change in Inventory had its largest YoY gain of 570.38% in 2023, and its largest YoY loss of 838.62% in 2023.
  • Over the past 5 years, Nektar Therapeutics' Change in Inventory (Quarterly) stood at $2.4 million in 2020, then crashed by 80.38% to $471,000 in 2021, then crashed by 69.21% to $145,000 in 2022, then crashed by 838.62% to -$1.1 million in 2023, then dropped by 21.85% to -$1.3 million in 2024.
  • Its Change in Inventory was -$1.3 million in Q4 2024, compared to -$123,000 in Q3 2024 and -$212,000 in Q2 2024.